日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Review Article: Renal Safety Profiles of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, and Entecavir for the Treatment of Chronic Hepatitis B Infection-General and Special Populations

综述文章:替诺福韦艾拉酚胺、富马酸替诺福韦二吡呋酯和恩替卡韦治疗慢性乙型肝炎感染的肾脏安全性概况——一般人群和特殊人群

Mak, Lung-Yi; Hu, Tsung-Hui; Yap, Desmond Y H

Conditional survival after radiofrequency ablation for early-stage hepatocellular carcinoma

早期肝细胞癌射频消融术后的条件生存率

Yen, Yi-Hao; Moi, Sin-Hua; Kee, Kwong-Ming; Hung, Chao-Hung; Chen, Chien-Hung; Hu, Tsung-Hui; Wang, Jing-Houng; Lin, Chih-Yun; Lu, Sheng-Nan

Predictors of True Early Recurrence in Patients Undergoing Radiofrequency Ablation for Hepatocellular Carcinoma

预测接受射频消融治疗的肝细胞癌患者早期复发的因素

Yen, Yi-Hao; Kee, Kwong-Ming; Hung, Chao-Hung; Chen, Chien-Hung; Hu, Tsung-Hui; Wang, Jing-Houng; Lu, Sheng-Nan

Risk Factors of Post-Traumatic Stress Disorder Symptom Trajectories for ICU Bereaved Family Members

重症监护室丧亲家属创伤后应激障碍症状轨迹的风险因素

Wen, Fur-Hsing; Chuang, Li-Pang; Hu, Tsung-Hui; Huang, Chung-Chi; Chou, Wen-Chi; Tang, Siew Tzuh

Long-Term Hepatic and Extrahepatic Outcomes of Chronic Hepatitis C Patients After Sofosbuvir-Based Treatment (LONGHEAD Study)

索非布韦治疗慢性丙型肝炎患者的长期肝脏和肝外结局(LONGHEAD 研究)

Huang, Chung-Feng; Heo, Jeong; Chien, Rong-Nan; Baek, Yang-Hyun; Kao, Jia-Horng; Kim, Ju-Hyun; Chang, Ting-Tsung; Byun, Kwan-Soo; Chen, Jyh-Jou; Jeong, Sook-Hyang; Hu, Tsung-Hui; Kim, Young-Seok; Peng, Cheng-Yuan; Tak, Won-Young; Wang, Horng-Yuan; Yoon, Seung-Kew; Sheen, I-Shyan; Youn-Jae Lee; Hsu, Yu-Chun; Yim, Hyung-Joon; Tsai, Pei-Chien; Yeh, Ming-Lun; Ahn, Sang-Hoon; Dai, Chia-Yen; Paik, Seung-Woon; Huang, Jee-Fu; Kim, Yoon-Jun; Chuang, Wan-Long; Lim, Young-Suk; Yu, Ming-Lung

A long term bone and renal safety of TAF treatment on renal transplant recipients

TAF治疗对肾移植受者的长期骨骼和肾脏安全性

Yap, Desmond Y H; Wu, Cheng-Kun; Tang, Colin; Chang, Kuo-Chin; Lee, Wen-Chin; Lui, David T W; Ma, Maggie K M; Hu, Tsung-Hui; Chan, Tak Mao

Intensity-Modulated Proton Therapy for Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

强度调控质子疗法治疗伴有门静脉肿瘤血栓的肝细胞癌

Liu, Chieh-Min; Lai, Chia-Hsuan; Wang, Yu-Ming; Huang, Eng-Yen; Chen, Yen-Hao; Ou, Hsin-You; Hu, Tsung-Hui; Hung, Chao-Hung; Lu, Sheng-Nan; Chen, Wan-Yu; Huang, Bing-Shen; Cheng, Jen-Yu

Dynamic Muscle Atrophy Predicts Outcomes in Patients with Unresectable Hepatocellular Carcinoma Treated with First-Line Lenvatinib: A Retrospective Study in Taiwan

动态肌肉萎缩可预测接受一线乐伐替尼治疗的不可切除肝细胞癌患者的预后:一项台湾回顾性研究

Lee, Hsing-Yun; Chang, Ching-Di; Chen, Yen-Hao; Tsai, Ming-Chao; Wang, Jing-Houng; Lu, Sheng-Nan; Hu, Tsung-Hui; Hung, Chao-Hung; Chen, Chien-Hung; Kuo, Yuan-Hung

Comparing health insurance-reimbursed lenvatinib and self-paid atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma

比较医保报销的乐伐替尼与自费的阿特珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌患者的疗效

Kuo, Yuan-Hung; Chen, Yen-Hao; Tsai, Ming-Chao; Lu, Sheng-Nan; Hu, Tsung-Hui; Hung, Chao-Hung; Chen, Chien-Hung; Wang, Jing-Houng

Overall survival is comparable between percutaneous radiofrequency ablation and liver resection as first-line therapies for solitary 3-5 cm hepatocellular carcinoma

对于孤立性3-5厘米肝细胞癌的一线治疗,经皮射频消融术和肝切除术的总体生存率相当。

Chung, Shih-Da; Yong, Chee-Chien; Kee, Kwong-Ming; Lu, Sheng-Nan; Hu, Tsung-Hui; Wang, Jing-Houng; Hung, Chao-Hung; Chen, Chien-Hung; Liu, Yueh-Wei; Li, Wei-Feng; Wang, Chih-Chi; Yen, Yi-Hao; Lin, Chih-Yun